Pharmafile - Research and Development
Kite has announced the primary overall survival (OS) analysis results of a phase 3 study into Yescarta for the treatment of adult patients with...
A new drug to treat ovarian cancer is set to enter the phase 3 UP-NEXT trial imminently. Upifitamab rilsodotin is an antibody-drug conjugate (...
Faron Pharmaceuticals, a clinical stage biopharmaceutical company, has revealed positive FDA feedback and recommendations for its monotherapy for...
US-based Gilead Sciences and Nurix have announced that Gilead has exercised its option to exclusively license Nurix’s investigational targeted...
Features
Clinical trials are complex, multifaceted projects, and this makes them infamously expensive to run, but outsourcing to contract research...
Appointments
Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a wealth of experience across...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
Events
Friday, September 23, 2022 - Saturday, September 24, 2022
London, United Kingdom
Conference
After an innovative 2021 competition that saw our finalists...
